Global Aerosol Treatment Market is segmented By Product Type(Nebulizers (Jet nebulizers, Ultrasonic wave nebulizers, Vibrating mesh nebulizers), Metered-dose inhalers(Conventional pressurized inhalers & Soft mist inhalers), Dry powder inhalers(Single dose inhalers & Multi-dose inhalers), By Application(Asthma, Chronic obstructive pulmonary disease, Cystic fibrosis, Non-respiratory diseases), By End-User(Hospitals, Clinics, Ambulatory Surgical Centers, Individual), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Aerosol Treatment Market Overview
The Global Aerosol Treatment Market is predicted to reach at a high CAGR during the forecast period (2023-2030).
Aerosol treatment is the technique used to administer the medication directly into the lungs and their airways. It is usually a suspension of liquids or solids administered using a medical device such as an inhaler.
Source: DataM Intelligence Analysis (2021)
Aerosol Treatment Market Scope
Metrics |
Details |
Market CAGR |
High |
Segments Covered |
By Product Type, By Application, By End Users, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region |
Asia Pacific |
Largest Market Share |
North America |
For more insights Request Free Sample
Aerosol Treatment Market Dynamics
The aerosol treatment market growth is driven by the increasing prevalence of chronic respiratory conditions such as COPD, asthma, and pneumonia, the main advantage of the aerosol treatment is the usage of smaller doses, giving rapid response with minimal side effects. The diversified use of aerosol treatment to treat different indications and additional therapeutic effects is driving the growth of the aerosol treatment market.
The increasing prevalence of chronic respiratory diseases is expected to drive the growth in the forecast period
The major respiratory disorders currently cured using aerosol treatment include Asthma, COPD, Bronchiectasis, cystic fibrosis, pulmonary arterial hypertension, and infectious pulmonary diseases. As per the Center for Disease Control and Prevention (CDC), around 16 million people suffer from COPD. As per CDC, in the last decade, the prevalence of asthma in the U.S. has increased by 15%. For example, 3.8 million people in Canada had asthma, and 2.0 million had chronic obstructive pulmonary disease (COPD) in 2018. Respiratory diseases also lead to lost productivity and healthcare costs. The increasing burden of these diseases needs rapid intervention by increasing better treatment.
Side-effects associated with aerosol treatment is likely to hinder the market growth
A few reported adverse cases of oral candidiasis in patients who use aerosol treatment may hamper the growth of the market.
Source: DataM Intelligence Analysis (2021)
COVID-19 Impact on Aerosol Treatment Market
The World Health Organization (WHO), on January 30, 2020, declared the COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. According to a paper published by the Journal of Allergy and Clinical Immunology (JACI), in 2020, asthma and COPD patients appear to have increased their adherence to inhalation medications during the COVID-19. Moreover, some parts of developed countries such as the U.S. and the U.K. are experiencing shortages of bronchodilator inhalers such as albuterol inhalers, as hospitals utilize them for COVID-19 patients. Furthermore, according to data provided by the National Health Service (NHS), in 2020, the number of salbutamol inhalers prescribed by general practitioners (G.P.) in England raised by 63% between February 2020 and March 2020. Thus, COVID-19 infection uplifted growth and opportunities for manufacturers of the aerosol treatment market during the forecast period.
Aerosol Treatment Market Segment Analysis
The vibrating mesh nebulizers segment is expected to hold the largest share in this market segment
Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developments. Thus it was estimated that mesh nebulizers will be increasingly adopted in the coming future. This is due to the portability, convenience, and speed of treatment, owing to their low residual volumes and accurate lung delivery. Thus, technological advancements in mesh nebulizers, with the development of an innovative solution, are likely to further drive the growth of the market in the future. An analysis of EU and US clinical trial databases has shown that mesh nebulizers are now preferred overjet nebulizers for clinical trials sponsored by pharmaceutical companies. The results show a strong preference for the use of mesh nebulizers in trials involving high cost and niche therapy areas. Built-in capability to optimize the way patients use their mesh nebulizer and manage their disease will further increase uptake.
The asthma segment is expected to hold the largest share in this market segment
The asthma segment had the highest share in the application segment. Asthma was highly prevalent around the world and affected 262 million people in 2019. Asthma is a long-term condition where the air passages in the lungs are partially blocked due to inflammation and muscle tightening. Symptoms of asthma include wheeze, cough, shortness of breath and tightness in the chest.
The hospital's segment is expected to hold the largest share in this market segment
The most common end-users are hospitals. Every year there are approximately 800,000 hospitalizations for Chronic obstructive pulmonary disease (COPD) in the United States, the third leading cause of death in the country. Additionally, 500,000 hospitalizations for asthma occur yearly and affect about 24 million Americans. Treatments for both COPD and asthma have similar protocols which have been well established over the years.
Source: DataM Intelligence Analysis (2021)
Aerosol Treatment Market Geographical Share
North America region holds the largest market share of the global aerosol treatment market
North America region is dominating the global aerosol treatment market accounted for the largest market share. As the population in the region follows a fast-moving lifestyle, patients are looking for more inhalers that can be transferred easily in a time of need for patients suffering from asthma and other airway diseases.
In addition, healthcare cost containment issues, the post-economic crises in the United States, have required the government to introduce new strategies to reduce patient stays in hospitals. This provided the impetus to homecare services, which in turn, created a favorable environment for the growth of the aerosol treatment market.
Source: DataM Intelligence Analysis (2021)
Aerosol Treatment Companies
The global aerosol treatment market is highly competitive with the presence of global companies. Some of the key players which are contributing to the growth of the market include Merck, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, Teva Pharmaceuticals, Opko Health, Omron Healthcare, Medtronic, GE Healthcare. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally.
Aerosol Treatment Market Key Companies to Watch
GlaxoSmithKline
Overview: GlaxoSmithKline plc is a British multinational pharmaceutical company headquartered in Brentford, UK. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham. The business segments include Pharmaceuticals, Vaccines and Consumer healthcare. GSK is extending 50 years of leadership in respiratory medicine with continued innovation in the development of treatments for asthma, chronic obstructive pulmonary disease (COPD), and other debilitating respiratory conditions. It operates its business in over 115 countries worldwide.
Product Portfolio: The Pharmaceuticals business has a broad portfolio of innovative and established medicines in respiratory, HIV, immuno-inflammation and oncology.
Why Purchase the Report?
- Visualize the composition of the aerosol treatment market segmentation by product type, application, end-user and region highlighting the key commercial assets and players.
- Identify commercial opportunities in the aerosol treatment market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of aerosol treatment market-level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key product of all major market players
The global aerosol treatment market report would provide access to an approx. 40+ market data table, 45+ figures and 180 pages.
Target Audience
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers